Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination

Lei Yu,1 Yun Jing,2 Shan Ma,1 Fei Li,1 Yun-Feng Zhang11Department of Thoracic Surgery, 2Department of Neurology, Beijing Tongren Hospital, Capital Medical University, People’s Republic of ChinaBackground: The treatment of thymoma or thymic carcinoma with pleural dissemination remains contr...

Full description

Bibliographic Details
Main Authors: Yu L, Jing Y, Ma S, Li F, Zhang YF
Format: Article
Language:English
Published: Dove Medical Press 2013-05-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/cytoreductive-surgery-combined-with-hyperthermic-intrapleural-chemothe-a13019
id doaj-7742617bcd7b434d81d9d949104c04e6
record_format Article
spelling doaj-7742617bcd7b434d81d9d949104c04e62020-11-25T00:58:21ZengDove Medical PressOncoTargets and Therapy1178-69302013-05-012013default517521Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural disseminationYu LJing YMa SLi FZhang YFLei Yu,1 Yun Jing,2 Shan Ma,1 Fei Li,1 Yun-Feng Zhang11Department of Thoracic Surgery, 2Department of Neurology, Beijing Tongren Hospital, Capital Medical University, People’s Republic of ChinaBackground: The treatment of thymoma or thymic carcinoma with pleural dissemination remains controversial due to the unpredictable natural history of this tumor. Our study discusses the combination of cytoreductive surgery with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination.Methods: From February 2008 to January 2010, there were four patients with pleural thymoma metastases undergoing cytoreductive surgery and intrathoracic hyperthermic perfusion with chemotherapy at our department. After video-assisted thoracoscopic surgery, the hyperthermic perfusion system was set up for hyperthermic intrapleural chemotherapy. The thoracic cavity was perfused at a speed of approximately 1.8–2.3 L/min with 0.9% normal saline. The intrathoracic temperature remained between 42°C and 43°C. The perfusion process lasted for 2 hours.Results: There were no perioperative deaths. During the hyperthermic perfusion, the patient's core temperature varied from 36.3°C and 39.3°C and pulse varied from 59 beats/min and 126 beats/min. Intraoperative sinus tachycardia occurred in two elderly patients. No hematologic toxicity and nephrotoxicity was observed within 1 week after surgery. Postoperative pneumonia occurred in one elderly patient. Patients were followed up for 1–4 years. One elderly patient died of heart failure 1 year after surgery. There were no patients with local recurrence or metastases to distant sites.Conclusions: Cytoreductive surgery and intrathoracic hyperthermic perfusion with chemotherapy may be effective in treating thymoma or thymic carcinoma with pleural dissemination and has an encouraging impact on the patients’ long-term survival.Keywords: thymoma, pleural dissemination, surgery, hyperthermia, chemotherapyhttp://www.dovepress.com/cytoreductive-surgery-combined-with-hyperthermic-intrapleural-chemothe-a13019
collection DOAJ
language English
format Article
sources DOAJ
author Yu L
Jing Y
Ma S
Li F
Zhang YF
spellingShingle Yu L
Jing Y
Ma S
Li F
Zhang YF
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
OncoTargets and Therapy
author_facet Yu L
Jing Y
Ma S
Li F
Zhang YF
author_sort Yu L
title Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
title_short Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
title_full Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
title_fullStr Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
title_full_unstemmed Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
title_sort cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2013-05-01
description Lei Yu,1 Yun Jing,2 Shan Ma,1 Fei Li,1 Yun-Feng Zhang11Department of Thoracic Surgery, 2Department of Neurology, Beijing Tongren Hospital, Capital Medical University, People’s Republic of ChinaBackground: The treatment of thymoma or thymic carcinoma with pleural dissemination remains controversial due to the unpredictable natural history of this tumor. Our study discusses the combination of cytoreductive surgery with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination.Methods: From February 2008 to January 2010, there were four patients with pleural thymoma metastases undergoing cytoreductive surgery and intrathoracic hyperthermic perfusion with chemotherapy at our department. After video-assisted thoracoscopic surgery, the hyperthermic perfusion system was set up for hyperthermic intrapleural chemotherapy. The thoracic cavity was perfused at a speed of approximately 1.8–2.3 L/min with 0.9% normal saline. The intrathoracic temperature remained between 42°C and 43°C. The perfusion process lasted for 2 hours.Results: There were no perioperative deaths. During the hyperthermic perfusion, the patient's core temperature varied from 36.3°C and 39.3°C and pulse varied from 59 beats/min and 126 beats/min. Intraoperative sinus tachycardia occurred in two elderly patients. No hematologic toxicity and nephrotoxicity was observed within 1 week after surgery. Postoperative pneumonia occurred in one elderly patient. Patients were followed up for 1–4 years. One elderly patient died of heart failure 1 year after surgery. There were no patients with local recurrence or metastases to distant sites.Conclusions: Cytoreductive surgery and intrathoracic hyperthermic perfusion with chemotherapy may be effective in treating thymoma or thymic carcinoma with pleural dissemination and has an encouraging impact on the patients’ long-term survival.Keywords: thymoma, pleural dissemination, surgery, hyperthermia, chemotherapy
url http://www.dovepress.com/cytoreductive-surgery-combined-with-hyperthermic-intrapleural-chemothe-a13019
work_keys_str_mv AT yul cytoreductivesurgerycombinedwithhyperthermicintrapleuralchemotherapytotreatthymomaorthymiccarcinomawithpleuraldissemination
AT jingy cytoreductivesurgerycombinedwithhyperthermicintrapleuralchemotherapytotreatthymomaorthymiccarcinomawithpleuraldissemination
AT mas cytoreductivesurgerycombinedwithhyperthermicintrapleuralchemotherapytotreatthymomaorthymiccarcinomawithpleuraldissemination
AT lif cytoreductivesurgerycombinedwithhyperthermicintrapleuralchemotherapytotreatthymomaorthymiccarcinomawithpleuraldissemination
AT zhangyf cytoreductivesurgerycombinedwithhyperthermicintrapleuralchemotherapytotreatthymomaorthymiccarcinomawithpleuraldissemination
_version_ 1725220563379552256